Jeruzalės veterinarijos klinika, UAB - financials and debts

Company age: 32 y. 8 mo.

Update

Jeruzalės veterinarijos klinika - Company finances

EUR
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 632,700 636,515
Profit before tax - -
Net profit 21,565 55,331
Equity -11,072 44,259
Liabilities 77,034 59,278
Non-current assets 27,454 62,406
Current assets 41,438 43,071
Total assets 68,892 105,477
Taxes paid
STI taxes 148,100 114,421
Social insurance contributions 63,669 55,989
Financial indicators
Revenue change y/y - +0.6%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 31.3% 52.5%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. - 125.0%
Profit margin Net profit margin. Shows the overall profitability of the company. 3.4% 8.7%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. - -
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. - 1.3
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 47,158 63,126

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Jeruzalės veterinarijos klinika - Social security debts

From To Debt, €
2023-07-19 2023-07-20 1789.75

Jeruzalės veterinarijos klinika - VMI tax arrears

From To Overdue, €
2026-09-18 2026-09-23 0.01
2026-08-12 2026-08-17 0.01
2026-01-16 2026-01-24 0.79
2025-12-18 2025-12-29 0.36

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Jeruzales veterinarijos klinika, UAB (code 122325079) is a Private Limited Liability Company engaged in veterinary activities. In the latest financial year, 2025, the company generated revenue of €636.5K, up 0.6% year on year, and net profit of €55.3K, compared with €21.6K in 2024. The profit margin improved to 8.7% from 3.4%, indicating a stronger earnings profile despite only modest sales growth. Over the two-year period, revenue remained broadly stable while profitability strengthened materially. The balance sheet also improved: total assets increased to €105.5K from €68.9K, equity recovered from -€11.1K to €44.3K, and liabilities declined to €59.3K from €77.0K. Key ratios for 2025 show a high return on equity of 125.0%, return on assets of 52.5%, debt-to-equity of 1.34, and asset turnover of 6.03x. Revenue per employee was €63.7K, with profit per employee of €5.5K.